Last week, for the second year in a row, the House of Representatives approved a spending bill amendment to protect all state, territory and tribal marijuana programs from federal interference.

Happy August, Star Gazers! July was a hard month to beat for astrology and astronomy fans alike.

The number of people working in the U.S. cannabis industry is expected to jump to 240,000-295,000 by the end of 2020, slightly higher than the number of computer programmers employed in the United States.

Amid the ongoing expansion of New Jersey’s medical marijuana market as well as the anticipated victory of recreational legalization at the ballot box in November, some of the state’s cannabis companies are investing heavily in cultivation build-outs and other infrastructure to meet an expected surge in demand.

Over the last few years, Gage Green Group’s flagship strain, Mendo Breath, has found its way into the gardens of some of the best growers in the world.

Novamind acquires Utah-based Cedar Psychiatry and Cedar Clinical Research for CAD$3.05 million.

For many decades vacationers have flocked to cannabis hotspots like Amsterdam, Jamaica, Thailand, and other international destinations often associated with cannabis, albeit unregulated cannabis.

The communal experience of cannabis, something that has always been closely linked to joints and vapes, has now been put on an indefinite pause. Edibles to the rescue!

The City College of San Francisco has announced a two-year cannabis studies degree starting this fall; the degree program is based on three courses: Introduction to Cannabis, Anthropology of Cannabis, and Psychology of Psychoactive Drugs.

Big Pharma has strong incentives to embrace psychedelics. But will its predatory business model turn drug companies against these drugs?